James F. Fitzgibbons

Randomized Phase II Trial of Single-Agent Amrubicin or Topotecan as Second-Line Treatment in Patients With Small-Cell Lung Cancer Sensitive to First-Line Platinum-Based Chemotherapy

Robert M. Jotte, Paul Conkling, Craig H. Reynolds et al. · Journal of Clinical Oncology · 2010 · 172 citations

Red cell age-related changes of hemoglobins AIa+b and AIc in normal and diabetic subjects.

James F. Fitzgibbons, R. D. Koler, Richard T. Jones · Journal of Clinical Investigation · 1976 · 166 citations · Full text

Heme Homeostasis, Insulin Management, Physiology +12

Pseudallescheria boydii Brain Abscess

David L. Dworzack, Richard B. Clark, Winslow J. Borkowski et al. · Medicine · 1989 · 75 citations

Miconazole Dosage, Klebsiella Pneumoniae, Lymphatic Filariasis +12

Results of a randomized phase II trial of amrubicin (AMR) versus topotecan (Topo) in patients with extensive-disease small cell lung cancer (ED-SCLC) sensitive to first-line platinum-based chemotherapy

Robert M. Jotte, Paul Conkling, Craig H. Reynolds et al. · Journal of Clinical Oncology · 2009 · 16 citations

Sensitive Ed-sclc, Amr Pts, Medicine +15

A fluorometric procedure for estimation of galactose-1-phosphate uridylyltransferase activity in red blood cells

John H. Copenhaver, Lawrence C. Bausch, James F. Fitzgibbons · Analytical Biochemistry · 1969 · 12 citations

Aldo-keto Reductase, Cellular Enzymology, Biochemistry +11